CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-07 | ENRIGHT PATRICK G Director | Grant or award | +3,507 | 28,184 | ||
| 2025-08-07 | Hamill Laura Director | Grant or award | +3,507 | 8,738 | ||
| 2025-08-07 | Kennedy Patrick Director | Grant or award | +3,507 | 8,661 | ||
| 2025-08-07 | McSharry Heather Ann Director | Grant or award | +3,507 | 22,408 | ||
| 2025-08-07 | ORiordan Anne Director | Grant or award | +3,507 | 18,305 | ||
| 2025-08-07 | RIEDEL NORBERT G Director | Grant or award | +3,507 | 8,829 | ||
| 2025-08-07 | Smith Mark Douglas Director | Grant or award | +3,507 | 12,642 | ||
| 2025-08-07 | Winningham Rick E Director | Grant or award | +3,507 | 16,198 | ||
| 2025-08-07 | Mulligan Seamus Director | Grant or award | +3,507 | 1,179,613 | ||
| 2025-08-07 | GALA RENEE D President & CEO | Grant or award | +18,808 | 107,869 | ||
| 2025-08-05 | Pearce Samantha EVP, Chief Commercial Officer | Shares withheld for taxes | −577 | $116.10 | $67K | 40,815 |
| 2025-08-01 | COZADD BRUCE C Chairman & CEO | Sale 10b5-1 | −1,000 | $113.21 | $113K | 435,973 |
| 2025-07-01 | COZADD BRUCE C Chairman & CEO | Sale 10b5-1 | −500 | $105.26 | $53K | 437,473 |
| 2025-07-01 | COZADD BRUCE C Chairman & CEO | Sale 10b5-1 | −500 | $110.00 | $55K | 436,973 |
| 2025-06-03 | COZADD BRUCE C Chairman & CEO | Sale 10b5-1 | −500 | $110.00 | $55K | 437,973 |
| 2025-06-02 | COZADD BRUCE C Chairman & CEO | Sale 10b5-1 | −500 | $107.90 | $54K | 438,473 |
| 2025-05-12 | Mulligan Seamus Director | Purchase | +1,621 | $103.00 | $167K | 101,621 |
| 2025-05-09 | Mulligan Seamus Director | Purchase | +80,684 | $98.10 | $7.9M | 80,684 |
| 2025-05-09 | Mulligan Seamus Director | Purchase | +19,216 | $98.91 | $1.9M | 99,900 |
| 2025-05-09 | Mulligan Seamus Director | Purchase | +100 | $99.71 | $10K | 100,000 |
Page 11 of 31 · 614 trades